Behçet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Kuranov, Alexandr B ^a   Kötter, Ina ^b   Henes, Jörg C ^a   Abisheva, Saule T ^c   Steiert, Ingeborg ^a   Riewerts, Florian ^a   Momynaliev, Kuvat T ^d   Müller, Claudia A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Interdisciplinary Centre for Rheumatology Stuttgart (ZIRS)   (Germany)

^c Institute for Scientific Research of Traumatology and Orthopedics   (Kazakhstan)

^d NATIONAL CENTER FOR BIOTECHNOLOGY   (Kazakhstan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA ANTIGEN CLASS 1; HLA B51 ANTIGEN; HLA BW4 80I ANTIGEN; ISOLEUCINE; UNCLASSIFIED DRUG; HLA A ANTIGEN; HLA B ANTIGEN; HLA-A*26 ANTIGEN; HLA-BW4 ANTIGEN;

ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DNA ISOLATION; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; GERMAN; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; RACE; TURK (PEOPLE); ALLELE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GERMANY; RISK; RISK FACTOR; TURKEY;

ALLELES; BEHCET SYNDROME; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-B51 ANTIGEN; HUMANS; ISOLEUCINE; ODDS RATIO; RISK FACTORS; TURKEY;

EID: 84902514943     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4569     Document Type: Article

References (34)

1. International Team for the Revision of the International Criteria for Behçet's Disease Revsion of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 2006, 42:S14-S15. International Team for the Revision of the International Criteria for Behçet's Disease.
2. Zouboulis CC. Epidemiology of Adamantiades-Behçet's disease. Annales de Médecine Interne (Paris) 1999, 150:488-498.
3. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Söhnchen R, Weber H, Gollnick HP, Hölzle E, Fritz K, Licht T, Orfanos CE. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997, 38:411-422.
4. Ohno S, Asanuma T, Sugiura S, Wakisaka A, Aizawa M, Itakura K. HLA-Bw51 and Behçet's disease. JAMA 1978, 240:529.
5. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009, 61:1287-1296. 10.1002/art.24642, 3867978, 19790126.
6. Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, Yamakawa R, Yuasa T, Fujioka T, Ohno S, Bahram S, Mizuki N. Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis 2010, 69:747-754. 10.1136/ard.2009.108571, 19684014.
7. Kötter I, Vonthein R, Müller CA, Günaydin I, Zierhut M, Stübiger N. Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 2004, 31:133-139.
8. Itoh Y, Inoko H, Kulski JK, Sasaki S, Meguro A, Takiyama N, Nishida T, Yuasa T, Ohno S, Mizuki N. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006, 67:390-394. 10.1111/j.1399-0039.2006.00586.x, 16671946.
9. Chung YM, Yeh TS, Sheu MM, Chen MS, Wen MS, Tsai HY, Liao HR. Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 1990, 89:413-417.
10. Mizuki N, Ohno S, Ando H, Chen L, Palimeris GD, Stavropoulos-Ghiokas E, Ishihara M, Goto K, Nakamura S, Shindo Y, Isobe K, Ito N, Inoko H. A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens 1997, 50:57-60. 10.1111/j.1399-0039.1997.tb02835.x, 9243757.
11. Piga M, Mathieu A. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford) 2011, 50:299-310. 10.1093/rheumatology/keq331, 21059670.
12. Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Casali B, Kötter I, Gutierrez-Achury J, Wijmenga C, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013, 45:319-324. 10.1038/ng.2551, 23396137.
13. Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Ugurlu S, Erer B, Abaci N, Ustek D, Meguro A, Ueda A, Takeno M, Inoko H, Ombrello MJ, Satorius CL, Maskeri B, Mullikin JC, Sun HW, Gutierrez-Cruz G, Kim Y, Wilson AF, Kastner DL, Gül A, Remmers EF. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci USA (PNAS) 2013, 110:8134-8139.
14. Zapata C. The D' measure of overall gametic disequilibrium between pairs of multi-allelic loci. Evolution 2000, 54:1809-1812.
15. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
16. Sanjanwala B, Draghi M, Norman PJ, Guethlein LA, Parham P. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J Immunol 2008, 181:6293-6300. 10.4049/jimmunol.181.9.6293, 2634290, 18941220.
17. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991, 51:1197-1203. 10.1097/00007890-199106000-00010, 2048196.
18. Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai De E. Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. Am J Transplant 2011, 11:817-825. 10.1111/j.1600-6143.2011.03454.x, 3072270, 21401872.
19. Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, Nigra TP. Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 1980, 66:670-675. 10.1172/JCI109903, 371640, 6932404.
20. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004, 64:215-225. 10.1111/j.0001-2815.2004.00290.x, 15304001.
21. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, Chang C, Boyle LH, Taylor CJ, Trowsdale J, Allen RL. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol 2011, 186:2990-2997. 10.4049/jimmunol.1003078, 21270408.
22. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 2004, 34:1673-1679. 10.1002/eji.200425089, 15162437.
23. Salter RD, Parham P. Mutually exclusive public epitopes of HLA-A, B, C molecules. Hum Immunol 1989, 26:85-89.
24. Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, Lanier LL, Parham P. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 1997, 158:5237-5241.
25. Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011, 476:96-100. 10.1038/nature10237, 3194000, 21814282.
26. Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease. Rheumatol Int 2004, 24:212-216.
27. Ahn JK, Chung H, Lee DS, Yu YS, Yu HG. CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis. J Immunol 2005, 175:6133-6142. 10.4049/jimmunol.175.9.6133, 16237110.
28. Middleton D, Meenagh A, Sleator C, Gourraud PA, Ayna T, Tozkir H, Köse AA, Azizleri G, Diler AS. No association of KIR genes with Behcet's disease. Tissue Antigens 2007, 70:435-438. 10.1111/j.1399-0039.2007.00929.x, 17868255.
29. Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, Sharma D, Graef T, McQueen KL, Guethlein LA, Carrington CV, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath DD, Shiau MY, Stephens HA, Struik S, Tyan D, Verity DH, Vaughan RW, Davis RW, et al. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res 2009, 19:757-769. 10.1101/gr.085738.108, 2675964, 19411600.
30. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740. 10.1038/ng2035, 17496894.
31. Saruhan-Direskeneli G, Uyar FA, Cefle A, Onder SC, Eksioglu-Demiralp E, Kamali S, Inanç M, Ocal L, Gül A. Expression of KIR and C-type lectin receptors in Behcet's disease. Rheumatology (Oxford) 2004, 43:423-427. 10.1093/rheumatology/keh063, 14679294.
32. O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 2007, 178:235-241. 10.4049/jimmunol.178.1.235, 17182560.
33. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, McVicar DW, Altfeld M. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 2011, 85:5970-5974. 10.1128/JVI.00412-11, 3126328, 21471246.
34. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011, 479:401-405. 10.1038/nature10517, 3723390, 22020283.